Skip to main content
S&P 5007,580.07-1.82%DOW51,770.31-1.09%NASDAQ25,437.00-2.86%BTC$77,415.00+0.36%ETH$2,246.32+1.22%GOLD$3,884.90-3.63%OIL$102.95+0.93%
Smart Investors Daily
SID Premium
The Cooper Companies, Inc. logo

NYSE · COO

The Cooper Companies, Inc.

Healthcare · Medical - Instruments & Supplies

$60.34

Down-$0.79 (-1.31%)

Updated Oct 31, 2026, 12:35 AM

SID Score

4.4/10

Composite research score

Smart Money

58/100

Neutral

Market cap
16.38B
P/E ratio
43.38
Dividend yield
0.00%
52-week range
$51.01 – $85.04
Volume
1.76M
Avg. volume
2.86M

Price performance · COO

COO price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Oct 29, 2026

COO closed at $60.34 after 20 trading sessions, up 6.03% for the selected period.

Last close
$60.34
Period change
+6.03%
Period low
$54.30
Period high
$61.65
Daily close
View OHLC price history
COO OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 29, 2026$60.04$60.44$59.57$60.341.76M
Oct 28, 2026$58.70$60.29$58.501$59.414.24M
Oct 27, 2026$60.95$60.95$59.48$59.882.17M
Oct 26, 2026$61.21$62.09$60.83$61.141.83M
Oct 23, 2026$61.28$61.735$60.46$61.211.82M
Oct 22, 2026$59.39$61.66$59.27$61.653.51M
Oct 21, 2026$58.67$59.38$58.425$58.972.15M
Oct 20, 2026$58.84$59.47$58.6715$59.122.05M
Oct 19, 2026$57.29$58.27$56.95$58.162.68M
Oct 16, 2026$58.00$58.25$57.37$57.943.77M
Oct 15, 2026$55.49$57.47$55.46$57.402.89M
Oct 14, 2026$54.59$55.24$53.92$54.883.41M
Oct 13, 2026$55.55$56.05$54.43$54.592.63M
Oct 12, 2026$54.38$55.88$54.10$55.5453.39M
Oct 9, 2026$54.32$54.75$53.85$54.373.18M
Oct 8, 2026$54.09$54.675$53.71$54.305.85M
Oct 7, 2026$56.33$56.495$54.66$54.754.55M
Oct 6, 2026$56.68$56.93$55.64$56.434M
Oct 5, 2026$56.37$57.01$55.73$56.773.95M
Oct 2, 2026$57.52$57.685$56.72$56.913.31M

Latest COO news

The latest Smart Investors Daily articles mentioning COO.

Stock researchCompany · Overview

COO research

Overview

Company profile and research snapshot.

Company profile

CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$91.67
Implied upside
—
Analysts
—
COO recent ratings
DateFirmRatingTarget
Oct 7, 2026BarclaysEqual-Weight—
Sep 15, 2026NeedhamBuy—
Sep 11, 2026MizuhoOutperform—
Sep 10, 2026JP MorganNeutral—
Sep 10, 2026Piper SandlerNeutral—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 23, 2026

Cooper Companies (COO) Stock Looks Undervalued On Current Earnings

Cooper Companies has climbed in recent weeks even though its longer term returns have been weak, which puts a spotlight on whether the current share price lines up with what its earnings justify. With fresh headlines around softer results and legal investigations still in view in late 2026, the question for you is how much profit power is already baked into the stock. Over the past 5 years the share price has fallen 40.8%, so any assessment of Cooper Companies today needs to weigh a...

Yahoo · Oct 20, 2026

3 S&P 500 Stocks We Find Risky

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By